المؤلفون: Guymer E., Littlejohn G.

مصطلحات الفهرس: fibromyalgia/et [Etiology], fibromyalgia/th [Therapy], headache/si [Side Effect], human, irritable colon, mood disorder, muscle stiffness, nausea/si [Side Effect], neurophysiology, patient education, psychotherapy, restless legs syndrome, review, sleep disorder, somnolence/si [Side Effect], transcranial magnetic stimulation, xerostomia/si [Side Effect], amitriptyline/cm [Drug Comparison], amitriptyline/dt [Drug Therapy], amitriptyline/pd [Pharmacology], analgesic agent/dt [Drug Therapy], analgesic agent/pd [Pharmacology], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/pd [Pharmacology], antidepressant agent/dt [Drug Therapy], antidepressant agent/pd [Pharmacology], cyclobenzaprine/dt [Drug Therapy], cyclobenzaprine/pd [Pharmacology], dextromethorphan/ae [Adverse Drug Reaction], dextromethorphan/dt [Drug Therapy], dextromethorphan/pd [Pharmacology], duloxetine/ae [Adverse Drug Reaction], duloxetine/dt [Drug Therapy], duloxetine/pd [Pharmacology], fluoxetine/dt [Drug Therapy], fluoxetine/pd [Pharmacology], gabapentin/dt [Drug Therapy], gabapentin/pd [Pharmacology], ketamine/ae [Adverse Drug Reaction], ketamine/dt [Drug Therapy], ketamine/pd [Pharmacology], milnacipran/ae [Adverse Drug Reaction], milnacipran/dt [Drug Therapy], milnacipran/pd [Pharmacology], moclobemide/cm [Drug Comparison], moclobemide/dt [Drug Therapy], moclobemide/pd [Pharmacology], monoamine oxidase inhibitor/dt [Drug Therapy], monoamine oxidase inhibitor/pd [Pharmacology], nonsteroid antiinflammatory agent/dt [Drug Therapy], nonsteroid antiinflammatory agent/pd [Pharmacology], opiate/dt [Drug Therapy], opiate/pd [Pharmacology], paracetamol/dt [Drug Therapy], paracetamol/pd [Pharmacology], pramipexole/dt [Drug Therapy], pramipexole/pd [Pharmacology], pregabalin/ae [Adverse Drug Reaction], pregabalin/dt [Drug Therapy], pregabalin/pd [Pharmacology], serotonin antagonist/dt [Drug Therapy], serotonin antagonist/pd [Pharmacology], serotonin noradrenalin reuptake inhibitor/dt [Drug Therapy], serotonin noradrenalin reuptake inhibitor/pd [Pharmacology], serotonin uptake inhibitor/it [Drug Interaction], serotonin uptake inhibitor/dt [Drug Therapy], serotonin uptake inhibitor/pd [Pharmacology], tramadol/it [Drug Interaction], tramadol/dt [Drug Therapy], tramadol/pd [Pharmacology], tricyclic antidepressant agent/ae [Adverse Drug Reaction], tricyclic antidepressant agent/it [Drug Interaction], tricyclic antidepressant agent/dt [Drug Therapy], tricyclic antidepressant agent/pd [Pharmacology], tropisetron/dt [Drug Therapy], tropisetron/pd [Pharmacology], venlafaxine/dt [Drug Therapy], venlafaxine/pd [Pharmacology], pain, anxiety, chronic fatigue syndrome, clinical feature, cognitive defect/si [Side Effect], comorbidity, constipation/si [Side Effect], dizziness/si [Side Effect], dysesthesia, emotional stress, exercise, fatigue, fibromyalgia/dt [Drug Therapy], fibromyalgia/di [Diagnosis], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31228
Click here for full text options
LibKey Link

المؤلفون: Guymer E., Littlejohn G.

مصطلحات الفهرس: fibromyalgia/et [Etiology], fibromyalgia/th [Therapy], headache/si [Side Effect], human, irritable colon, mood disorder, muscle stiffness, nausea/si [Side Effect], neurophysiology, patient education, psychotherapy, restless legs syndrome, review, sleep disorder, somnolence/si [Side Effect], transcranial magnetic stimulation, xerostomia/si [Side Effect], amitriptyline/cm [Drug Comparison], amitriptyline/dt [Drug Therapy], amitriptyline/pd [Pharmacology], analgesic agent/dt [Drug Therapy], analgesic agent/pd [Pharmacology], anticonvulsive agent/dt [Drug Therapy], anticonvulsive agent/pd [Pharmacology], antidepressant agent/dt [Drug Therapy], antidepressant agent/pd [Pharmacology], cyclobenzaprine/dt [Drug Therapy], cyclobenzaprine/pd [Pharmacology], dextromethorphan/ae [Adverse Drug Reaction], dextromethorphan/dt [Drug Therapy], dextromethorphan/pd [Pharmacology], duloxetine/ae [Adverse Drug Reaction], duloxetine/dt [Drug Therapy], duloxetine/pd [Pharmacology], fluoxetine/dt [Drug Therapy], fluoxetine/pd [Pharmacology], gabapentin/dt [Drug Therapy], gabapentin/pd [Pharmacology], ketamine/ae [Adverse Drug Reaction], ketamine/dt [Drug Therapy], ketamine/pd [Pharmacology], milnacipran/ae [Adverse Drug Reaction], milnacipran/dt [Drug Therapy], milnacipran/pd [Pharmacology], moclobemide/cm [Drug Comparison], moclobemide/dt [Drug Therapy], moclobemide/pd [Pharmacology], monoamine oxidase inhibitor/dt [Drug Therapy], monoamine oxidase inhibitor/pd [Pharmacology], nonsteroid antiinflammatory agent/dt [Drug Therapy], nonsteroid antiinflammatory agent/pd [Pharmacology], opiate/dt [Drug Therapy], opiate/pd [Pharmacology], paracetamol/dt [Drug Therapy], paracetamol/pd [Pharmacology], pramipexole/dt [Drug Therapy], pramipexole/pd [Pharmacology], pregabalin/ae [Adverse Drug Reaction], pregabalin/dt [Drug Therapy], pregabalin/pd [Pharmacology], serotonin antagonist/dt [Drug Therapy], serotonin antagonist/pd [Pharmacology], serotonin noradrenalin reuptake inhibitor/dt [Drug Therapy], serotonin noradrenalin reuptake inhibitor/pd [Pharmacology], serotonin uptake inhibitor/it [Drug Interaction], serotonin uptake inhibitor/dt [Drug Therapy], serotonin uptake inhibitor/pd [Pharmacology], tramadol/it [Drug Interaction], tramadol/dt [Drug Therapy], tramadol/pd [Pharmacology], tricyclic antidepressant agent/ae [Adverse Drug Reaction], tricyclic antidepressant agent/it [Drug Interaction], tricyclic antidepressant agent/dt [Drug Therapy], tricyclic antidepressant agent/pd [Pharmacology], tropisetron/dt [Drug Therapy], tropisetron/pd [Pharmacology], venlafaxine/dt [Drug Therapy], venlafaxine/pd [Pharmacology], pain, anxiety, chronic fatigue syndrome, clinical feature, cognitive defect/si [Side Effect], comorbidity, constipation/si [Side Effect], dizziness/si [Side Effect], dysesthesia, emotional stress, exercise, fatigue, fibromyalgia/dt [Drug Therapy], fibromyalgia/di [Diagnosis], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31228
LibKey Link